Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
Liana K. Billings, Francesco Andreozzi, Marie Frederiksen, Pierre Gourdy, Amoolya Gowda, Linong Ji, Laura Pletsch‐Borba, Ryo Suzuki, A. G. Unnikrishnan, André Gustavo Daher Vianna
Topics & Concepts
MedicineOpen labelType 2 diabetesDiabetes mellitusInsulinRandomized controlled trialMEDLINEInternal medicineEndocrinologyLawPolitical scienceDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research